There are a number of approvals coming this fall in cancer therapy. Based on the latest research, OncoHealth’s oncology team expects the new indications to bring both an increase in cancer survival benefits and an increase in spend for payers.

This research recap summarizes 5 studies presented at the 2023 ASCO Annual Meeting that will influence plan policy decisions and utilization management strategies.

Fill out the form below to download the recap.